BSE: JBCHEPHARM - J. B. Chemicals & Pharmaceuticals Limited

半年間の収益性: -20.19%
配当利回り: +0.73%

プロモーションスケジュール J. B. Chemicals & Pharmaceuticals Limited


会社について J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI.

さらに詳しく
It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

ISIN INE572A01028
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.6872
Дивиденд ао 15.25
Сайт https://www.jbpharma.com
Цена ао 1518
週ごとの価格変動: -3.77% (1577.4)
月ごとの料金変更: -6.72% (1627.3)
3ヶ月間の価格変動: -17.54% (1840.85)
半年間の価格変動: -20.19% (1902)
年間の価格変動: -2.02% (1549.25)
3年間の価格推移: -3.32% (1570.1)
5年間の価格推移: +205.74% (496.5)
年初からの価格変動: -18.3% (1858.1)

過小評価

名前 意味 学年
P/S 7.25 1
P/BV 8.55 1
P/E 45.21 3
EV/EBITDA 5.46 9
合計: 5.13

効率

名前 意味 学年
ROA, % 14.64 4
ROE, % 20.45 7
合計: 6.33

配当金

名前 意味 学年
Div yield, % 0.729 1.83
DSI 0.8571 8.57
合計: 3.75

義務

名前 意味 学年
Debt/EBITDA 0.124 10
合計: 9.8

成長の衝動

名前 意味 学年
収益性 Revenue, % 97.83 9
収益性 Ebitda, % 731 10
収益性 EPS, % 106.67 10
合計: 9.8

スーパーバイザー 役職 支払い 生年
Mr. Nikhil Ashokkumar Chopra CEO & Whole-Time Director 65.45M 1973 (52 年)
Mr. Kunal Khanna President of Operations N/A 1980 (45 年)
Mr. Sridhar Bharadwaj Vice President of HR & Administration N/A 1967 (58 年)
Mr. Pradeep Kumar Singh President of Global Business N/A 1964 (61 年)
Mr. Himanshu Ranvah Vice President of Legal N/A 1985 (40 年)
Mr. Parmeshwar B. Bang Executive Vice President of Operations of Daman N/A 1968 (57 年)
Suresh Amin Assistant Vice President ? Human Resource
Mr. Narayan Saraf Chief Financial Officer 1980 (45 年)
Mr. Bhagwat Singh Deora Vice President of Finance & Accounts 1982 (43 年)
Mr. Suresh Bhise Vice President of Information & Technology 1966 (59 年)

住所: India, Mumbai, Cnergy IT Park - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.jbpharma.com